[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2140329B1 - USE OF MASLINIC ACID AS A PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASE CAUSED BY THE VIRUSES OF ACQUIRED IMMUNODEFICIENCY. - Google Patents

USE OF MASLINIC ACID AS A PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASE CAUSED BY THE VIRUSES OF ACQUIRED IMMUNODEFICIENCY.

Info

Publication number
ES2140329B1
ES2140329B1 ES9702528A ES9702528A ES2140329B1 ES 2140329 B1 ES2140329 B1 ES 2140329B1 ES 9702528 A ES9702528 A ES 9702528A ES 9702528 A ES9702528 A ES 9702528A ES 2140329 B1 ES2140329 B1 ES 2140329B1
Authority
ES
Spain
Prior art keywords
treatment
acquired immunodeficiency
protease inhibitor
viruses
maslinic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9702528A
Other languages
Spanish (es)
Other versions
ES2140329A1 (en
Inventor
Garcia Francisco Rivas
Carrillo De Albornoz Ant Osuna
Lazcano M Carmen Mascaro
Morrondo Rafael Najera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Granada
Original Assignee
Universidad de Granada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Granada filed Critical Universidad de Granada
Priority to ES9702528A priority Critical patent/ES2140329B1/en
Publication of ES2140329A1 publication Critical patent/ES2140329A1/en
Application granted granted Critical
Publication of ES2140329B1 publication Critical patent/ES2140329B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Utilización de ácido maslínico como inhibidor de serín proteasas para el tratamiento de enfermedades causadas por el virus de inmunodeficiencia adquirida. El ácido 2-alfa,3-bestadihidroxi-28-carboxioleaneno (ácido maslínico) se utiliza, sólo o en combinación con otros fármacos, para la obtención de preparados destinados al tratamiento de las enfermedades causadas en humanos y animales por el virus de inmunodeficiencia adquirida.Use of maslinic acid as a serine protease inhibitor for the treatment of diseases caused by the acquired immunodeficiency virus. 2-alpha, 3-bestadihydroxy-28-carboxyloleanene acid (maslinic acid) is used, alone or in combination with other drugs, to obtain preparations for the treatment of diseases caused in humans and animals by the acquired immunodeficiency virus .

ES9702528A 1997-12-04 1997-12-04 USE OF MASLINIC ACID AS A PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASE CAUSED BY THE VIRUSES OF ACQUIRED IMMUNODEFICIENCY. Expired - Fee Related ES2140329B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9702528A ES2140329B1 (en) 1997-12-04 1997-12-04 USE OF MASLINIC ACID AS A PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASE CAUSED BY THE VIRUSES OF ACQUIRED IMMUNODEFICIENCY.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9702528A ES2140329B1 (en) 1997-12-04 1997-12-04 USE OF MASLINIC ACID AS A PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASE CAUSED BY THE VIRUSES OF ACQUIRED IMMUNODEFICIENCY.

Publications (2)

Publication Number Publication Date
ES2140329A1 ES2140329A1 (en) 2000-02-16
ES2140329B1 true ES2140329B1 (en) 2000-10-16

Family

ID=8301402

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9702528A Expired - Fee Related ES2140329B1 (en) 1997-12-04 1997-12-04 USE OF MASLINIC ACID AS A PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASE CAUSED BY THE VIRUSES OF ACQUIRED IMMUNODEFICIENCY.

Country Status (1)

Country Link
ES (1) ES2140329B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249153B1 (en) * 2004-06-30 2007-02-16 Universidad De Granada MASLINIC ACID AS AN ADDITIVE FOR ANIMAL PRODUCTION.
ES2304322B1 (en) * 2007-03-23 2009-08-13 Universidad De Granada USE OF MASLINIC ACID AND ITS DERIVATIVES FOR THE INHIBITION OF ELASTASA AND FOR THE TREATMENT OF DISEASES AND SYMPTOMATOLOGIES WITH THEM RELATED.
ES2392522A1 (en) * 2011-05-28 2012-12-11 Universidad De La Laguna Composition for the maintenance of contact lenses that results effective against acanthamoeba ssp. (Machine-translation by Google Translate, not legally binding)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616578A (en) * 1993-08-26 1997-04-01 The Dupont Merck Pharmaceutical Company Method of treating human immunodeficiency virus infection using a cyclic protease inhibitor in combination with a reverse transcriptase inhibitor
US5750493A (en) * 1995-08-30 1998-05-12 Raymond F. Schinazi Method to improve the biological and antiviral activity of protease inhibitors
WO1997026880A2 (en) * 1996-01-26 1997-07-31 Pharmacia & Upjohn Company Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
MY126358A (en) * 1996-03-22 2006-09-29 Glaxo Group Ltd Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs
US5916919A (en) * 1997-06-27 1999-06-29 Dalhousie University Retrovirus protease inhibitors

Also Published As

Publication number Publication date
ES2140329A1 (en) 2000-02-16

Similar Documents

Publication Publication Date Title
BRPI0411900A (en) antiviral compounds and methods
BRPI0416936A (en) substituted imidazo ring systems and methods
EA200100524A1 (en) AMIDES OF ANTRANILIC ACID AND THEIR APPLICATION AS MEDICINES
ES2113881T3 (en) DERIVATIVES AND ANALOGS OF ACID 2-DESOXI-2,3-DIDEHIDRO-N-ACETIL NEURAMINICO AND ITS USE AS ANTIVIRAL AGENTS.
HN1999000124A (en) SUBSTITUTED PYRAZOLE DERIVATIVES.
EA199901031A1 (en) Derivatives of benzimidazole
MX9207334A (en) NUCLEIC ACIDS PEPTIDICS AND PHARMACEUTICAL FORMULATION CONTAINING THEM
GT199900166A (en) ADEQUATE CHEMICAL COMPOUND FOR USE AS AN ANTIVIRAL AGENT.-
ES2147294T3 (en) THERAPEUTIC COMPOUNDS.
ES2075011T3 (en) USE OF GAMMA-HYDROXYBUTRIC ACID SALTS TO PREPARE PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT OF ALCOHOLISM, AND THE COMPOSITIONS OBTAINED.
BR0009964A (en) Artificial peptides with surface activity and their use in the preparation of artificial surfactant
ES2115756T3 (en) SULPHONIC ACID DERIVATIVES USED IN THE TREATMENT OF VIRAL DISEASES.
ES2178779T3 (en) NEW AMIDAS OF PIRIDIL ALCANS ACIDS AS CYTOSTATIC AGENTS AND IMMUNOSUPPRESSORS.
EE04938B1 (en) Orthosubstituted anthranilic acid amides and their use as medicaments
ES2061453T3 (en) ANTIVIRAL PHARMACEUTICAL COMPOSITIONS CONTAINING HYPERICIN OR PSEUDOHIPERICINA.
GT200300244A (en) POSITIONAL ISOMERS OF IFN PEG ALFA 2A
DOP2002000481A (en) ACETIC ACID DERIVATIVES
ES2145360T3 (en) CRYSTALLINE SALTS AND STABLE TETRAHYDROPHOLIC ACID.
ES2158094T3 (en) ADDITION SALTS OF COMPOUND ACID OF 2,3,4,5-TETRAHIDRO-1H-3-BENZAZEPINA.
ES2140329B1 (en) USE OF MASLINIC ACID AS A PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASE CAUSED BY THE VIRUSES OF ACQUIRED IMMUNODEFICIENCY.
MX26167A (en) DERIVATIVES OF PIRIDIL-BENZOIC ACID FOR THE TREATMENT OF DISEASES RELATED TO LECOTRINE.
NO954702L (en) Aryl forming drugs
PA8509601A1 (en) "PIRAZOLO [4,3, e] NOVEDOUS REPLACED DIAZEPINS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, ITS USE AS MEDICINAL PRODUCTS AND PROCESSES TO PREPARE THEM
ES2184150T3 (en) USE OF DERIVATIVES OF ACIDS 7- (1-AMINOMETIL-2-OXA-7-AZA-BICICLO (3.3.0) OCT-7IL) -QUINOLONCARBOXILICO AND -NAFTIRIDONCARBOXILICO FOR THE TREATMENT OF INFECTIONS CAUSED BY HELICOBACTER PYLORRO AND GARDEN AFFECTIONS ASSOCIATED WITH THEM.
ES2131467B1 (en) USE OF MASLINIC ACID AS A SERIN-PROTEASE INHIBITOR FOR THE TREATMENT OF DISEASES CAUSED BY PARASITES OF THE GENE CRYPTOSPORIDIUM.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000216

Kind code of ref document: A1

Effective date: 20000216

FD2A Announcement of lapse in spain

Effective date: 20180326